If an individual wants to optimize for their own risk of dying from breast cancer, they should prioritize more effective screening rather than population efficiency or cost reduction.

“And if you're optimizing for your individual risk of dying from breast cancer, not population efficiency, not total societal cost, but your own outcome, the default should be to heir on the side of more effective screening and certainly not less.”